What is atenolol
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Understanding Atenolol: A Comprehensive Overview
Introduction to Atenolol: Beta 1-Adrenoceptor Antagonist
Atenolol is a selective beta 1-adrenoceptor antagonist, commonly known as a beta-blocker, with a duration of activity lasting at least 24 hours . It is primarily used in the treatment of cardiovascular conditions such as hypertension, angina pectoris, and certain types of arrhythmias .
Therapeutic Uses of Atenolol
Hypertension Management
Atenolol is effective in reducing blood pressure across all grades of hypertension. Comparative studies have shown that atenolol, when administered orally, lowers blood pressure to a similar extent as other beta-blockers, ACE inhibitors, calcium antagonists, and other antihypertensive agents . It is particularly effective in elderly patients and women with pregnancy-associated hypertension .
Angina Pectoris
Atenolol is also used in the prophylactic management of angina pectoris. Its long duration of beta-blocking activity allows for once-daily dosing, which is advantageous over other beta-blockers that may require multiple doses per day. It improves both objective and subjective indices in patients with stable angina .
Myocardial Infarction and Arrhythmias
Early intervention with intravenous atenolol followed by oral maintenance therapy has been shown to reduce infarct recurrence and cardiovascular mortality in patients with known or suspected myocardial infarction . Additionally, oral atenolol is used to prevent the recurrence of supraventricular arrhythmias once control is achieved through intravenous administration .
Pharmacological Properties
Cardioselectivity and Duration of Action
Atenolol is a cardioselective beta-blocker, meaning it primarily affects the heart's beta 1 receptors, with minimal impact on beta 2 receptors found in the lungs and other tissues. This selectivity makes it preferable for patients with asthma or diabetes mellitus, as it poses a lower risk of adverse effects related to these conditions.
Pharmacokinetics
Atenolol is rapidly but incompletely absorbed from the gastrointestinal tract, with an oral bioavailability of about 50-60%. It is not significantly bound to plasma proteins and is eliminated almost entirely unchanged in the urine. This necessitates dosage adjustments in patients with renal impairment.
Side Effects and Tolerability
Atenolol is generally well tolerated, with a side effect profile similar to other beta-blockers. Common side effects include cold extremities, fatigue, and diarrhea. Its low lipid solubility and limited brain penetration result in a lower incidence of central nervous system effects compared to non-selective beta-blockers like propranolol . However, it can cause bronchospasm in some patients, necessitating caution in those with obstructive airways disease.
Conclusion
Atenolol is a well-established beta 1-adrenoceptor antagonist with a broad range of therapeutic applications in cardiovascular medicine. It is effective in managing hypertension, angina pectoris, and certain arrhythmias, and has been associated with reduced cardiovascular mortality in patients with myocardial infarction. Its cardioselectivity and favorable side effect profile make it a valuable option for many patients, particularly those with concurrent conditions like asthma or diabetes.
Sources and full results
Most relevant research papers on this topic